Crinone gel vaginal 8% is indicated for:
Active ingredient: progesterone;
1 applicator (1.125 g of gel available for injection) contains 90 mg of progesterone (8% w/w);
Excipients: glycerin, mineral lung oil, hydrogenated palm oil glycerides, carbomer 974R, sorbic acid, polycarbophil, sodium hydroxide, purified water.
Treatment of infertility caused by luteal phase deficiency. After the established ovulation or alternatively on the 18th-21st day of the cycle, the contents of 1 applicator (1.125 g of 8% gel) are administered daily.
When used as part of IVF procedures. After laboratory confirmation of pregnancy, the contents of 1 applicator (1.125 g of 8% gel) are administered daily for 30 days.
The preparation is intended for single vaginal administration. The preparation that remains in the applicator after administration must be destroyed.
pregnant
Not recommended.
Children
Cannot be used by children.
Drivers
There have been cases of the development of drowsiness, patients who drive transport work with complex mechanisms should refrain from this type of activity.
Overdose cases are not expected, since each dose is administered using a separate disposable applicator. However, in case of an overdose, the preparation should be discontinued and symptomatic treatment should be started.
General disorders and reactions at the injection site. Often: headache, pain in the perineum or joints, memory impairment, weakness, pain, vaginal itching and other mild local reactions.
Although cases of interaction with other preparations have not been reported, Krinon® should not be used simultaneously with other preparations intended for vaginal administration.
Store at a temperature not exceeding 25°C. Do not freeze.
Keep out of the reach of children.
Do not use after the expiry date stated on the package.
Shelf life - 3 years.
There are no reviews for this product.